In conclusion, we show that METTL7B is an essential regulator of lineage specification in glioblastoma, raising the possibility that it could be exploited as a target for the development of therapeutic approaches specifically influencing plasticity-related glioblastoma features. Here, TMT1B is linked to glioblastoma.